Abortion A Eve Medical Center is categorized under Clinics in Miami, FL and active since 1996.
Abortion A Eve Medical Center was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214100 by the NAICS.
If you are seeking more information, feel free to contact Karen Bookbinder, Manager at the company’s single location by writing to 8603 South Dixie Highway # 100, Miami, Florida FL 33143 or by phoning (305) 670-9797. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Abortion A Eve Medical Center |
Contact Person: | Karen Bookbinder, Manager |
Address: | 8603 South Dixie Highway # 100, Miami, Florida 33143 |
Phone Number: | (305) 670-9797 |
Website Address: | evewomensmedical.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1996 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Clinics |
SIC Code: | 8011 |
NAICS Code: | 6214100 |
Share This Business: |
Abortion A Eve Medical Center was started in 1996 to provide professional Clinics under the SIC code 8011 and NAICS code 6214100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Karen Bookbinder, Manager for inquiries that concern Abortion A Eve Medical Center by calling the company number (305) 670-9797, as your correspondence is most welcome. Additionally, the physical location of the single location of Abortion A Eve Medical Center can be found at the coordinates 25.691169,-80.305658 as well as the street address 8603 South Dixie Highway # 100 in Miami, Florida 33143.
For its online presence, you may visit Abortion A Eve Medical Center’s website at evewomensmedical.com and engage with its social media outlets through on Twitter and on Facebook.